Phase 3 Readout~month

Phase 3 Topline: A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bev

Indication
Stage IV Nasopharyngeal Carcinoma AJCC v8; Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Other upcoming events for FATE

Phase 3 ReadoutPhase 3 Topline: An International, Multicenter, Open-label, Randomized, Comparative Study of the Efficacy and Safety
Phase 2 StartPhase 2 Start: A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe
Phase 2 StartPhase 2 Start: A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe
Phase 2 StartPhase 2 Start: Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor
Phase 3 ReadoutPhase 3 Topline: Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar